Health Condition 1: O244- Gestational diabetes mellitus
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
TANUH, AI Centre of Excellence
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed singleton pregnancy. Maternal age 20 to 45 years at enrolment, verified against hospital registration records . Gestational age (1st Trimester or early 2nd Trimester ) . Undergoing routine prenatal care. Voluntary consent for participation. Availability to participate for the duration of study (routine antenatal care and postpartum follow-up visits) .
Exclusion criteria
Exclusion criteria: Individuals with overt Diabetes (Type I or Type II) Autoimmune diseases, Chronic illnesses. Known Medicines that influence the glucose metabolism/ hormone treatments. Any other known complications that will affect the ultrasound imaging.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gestational Diabetes Mellitus(GDM) is usually diagnosed during the second trimester of pregnancy (between 24 and 28 weeks) using the oral glucose tolerance test (OGTT). This approach misses the opportunity for early identification and early preventive care. In addition, follow-up testing after delivery to assess the risk of diabetes is often inadequate. Early identification and intervention are important to reduce pregnancy-related complications and to lower the future risk of developing type 2 diabetes. This project aims to develop and validate an artificial intelligence (AI)-based multimodal risk prediction system using information collected as part of routine medical care and, where separately consented, additional comprehensive investigations.Improved early risk prediction for GDM may also help in better management of gestational diabetes during pregnancy. Timepoint: 1st Timester 2nd Trimester 3rd Trimester Every Quarter for upto 1 year Post Partum | — |
Secondary
| Measure | Time frame |
|---|---|
| This is an observational study. The study as a secondary outcome might help in identifying early markers of Gestational DiabetesTimepoint: 1st Trimester | — |
Countries
India
Contacts
Public ContactArihant Kochhar
Indian Institute of Science
Outcome results
None listed